Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

20.42
Delayed Data
As of Feb 24
 +0.27 / +1.34%
Today’s Change
18.16
Today|||52-Week Range
22.98
+5.48%
Year-to-Date
GLAXF Regular Dividend: GLAXF began trading ex-dividend on 02/22/17. A $23.00 dividend will be paid to shareholders of record as of 02/24/17.
Intercept (ICPT) Q4 Loss Wider than Expected, Revenues Beat
Feb 24 / Zacks.com - Paid Partner Content
Pfizer's Leukemia Candidate Gets Priority Review in U.S.
Feb 22 / Zacks.com - Paid Partner Content
Radius Health (RDUS) Posts Wider Loss in Q4
Feb 24 / Zacks.com - Paid Partner Content
Gilead Sciences Raises Dividend by Double Digits
Feb 22 / GuruFocus News - Paid Partner Content
Pharma Stock Roundup: Is BMY the Next Acquisition Target? Priority Review for PFE, No...
Feb 24 / Zacks.com - Paid Partner Content
Troubling Trial Data Weighed on Agenus Inc Stock Today
Feb 22 / MotleyFool.com - Paid Partner Content
Bayer (BAYRY) Misses on Q4 Earnings; Revenues in Line
Feb 23 / Zacks.com - Paid Partner Content
3 Things Gilead Sciences' CEO Just Said That You'll Want to Know
Feb 22 / MotleyFool.com - Paid Partner Content
Top Ranked Growth Stocks to Buy for February 23rd
Feb 23 / Zacks.com - Paid Partner Content
If You Want Yield, Look to the UK
Feb 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close20.15
Today’s open20.63
Day’s range20.29 - 20.63
Volume1,239
Average volume (3 months)5,287
Market cap$100.3B
Dividend yield4.94%
Data as of 2:55pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-90.47%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+2.96%
P/E ratio--
Price/Sales2.52
Price/Book71.57

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$37.6B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs